Results 231 to 240 of about 2,974,682 (398)
Roflumilast in Dermatology: A Newer Phosphodiesterase-4 Inhibitor
Suvesh Singh +2 more
doaj +1 more source
Erectile potentials of a new phosphodiesterase type 5 inhibitor, DA-8159, in diet-induced obese rats
Jae-Young Yu, Kyung-Koo Kang, Moohi Yoo
openalex +1 more source
OSA Initiates Histone Lactylation That Drives PDE4B/FUS/AGT Axis to Pulmonary Hypertension
This study illustrates how chronic intermittent hypoxia (CIH) in obstructive sleep apnea (OSA) leads to hypertension via increased oxidative stress and mitochondrial dysfunction in pulmonary artery smooth muscle cells (PASMCs), causing glycolytic dysregulation. Lactate accumulation enhances histone lactylation, upregulating phosphodiesterase 4B (PDE4B),
Li Yang +12 more
wiley +1 more source
Abstract Objective Accumulating evidence indicates that aberrant C1q‐C3 complement signaling in microglia and astrocytes drives synaptic dysfunction and neuronal loss. C1q‐mediated synaptic dysfunction disrupts neuronal circuitry balance and can lead to network hyperexcitability in epilepsy.
Yoonyi Jeong +5 more
wiley +1 more source
Phosphodiesterase Inhibitors for Pulmonary Hypertension [PDF]
GALIE', NAZZARENO +2 more
openaire +1 more source
The effects of single versus combined therapy using LIM-kinase 2 inhibitor and type 5 phosphodiesterase inhibitor on erectile function in a rat model of cavernous nerve injury-induced erectile dysfunction. [PDF]
Cho MC +7 more
europepmc +1 more source
The phosphodiesterase 4 inhibitor AA6216 suppresses activity of fibrosis-specific macrophages
Takashi Matsuhira +6 more
openalex +1 more source
The regulatory subunit RIβ of protein kinase A occurs in two variants that differ at residue 268 (A268 versus R268). This seemingly small substitution significantly changes cAMP sensitivity, basal kinase activity, and the dynamic behavior of the regulatory domains.
Maximilian Wallbott +6 more
wiley +1 more source

